{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:28:55Z","timestamp":1789014535337,"version":"build-2803163510"},"reference-count":17,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPR"],"DOI":"10.2147\/jpr.s453937","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T01:35:13Z","timestamp":1716255313000},"page":"1805-1814","source":"Crossref","is-referenced-by-count":8,"title":["Safety of Rimegepant in Patients Using Preventive Migraine Medications: A Subgroup Analysis of a Long-Term, Open-Label Study Conducted in the United States"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Gary","family":"Berman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Thiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Croop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Headache classification committee of the international headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211. doi:10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1212\/CON.0000000000000199","volume":"21","author":"Silberstein","year":"2015","journal-title":"Continuum"},{"key":"ref3","first-page":"17","volume":"99","author":"Ha","year":"2019","journal-title":"Am Fam Physician"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/head.14153","volume":"61","author":"Ailani","year":"2021","journal-title":"Headache"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s10194-023-01594-1","volume":"24","author":"Lampl","year":"2023","journal-title":"J Headache Pain"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/14728222.2020.1724285","volume":"24","author":"Wattiez","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e45560","DOI":"10.7759\/cureus.45560","volume":"15","author":"Muddam","year":"2023","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e2128544","DOI":"10.1001\/jamanetworkopen.2021.28544","volume":"4","author":"Yang","year":"2021","journal-title":"JAMA Network Open"},{"key":"ref9","unstructured":"Pfizer Inc. Nurtec ODT (rimegepant) Prescribing information. Available from: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=19036. Accessed June 6, 2023."},{"key":"ref10","unstructured":"Pfizer. Vydura (rimegepant) Prescribing Information. Available from: https:\/\/www.pfizerpro.co.uk\/medicine\/vydura. Accessed July 20, 2023."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3331024221141686","DOI":"10.1177\/03331024221141686","volume":"43","author":"Lipton","year":"2023","journal-title":"Cephalalgia"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0140-6736(19)31606-X","volume":"394","author":"Croop","year":"2019","journal-title":"Lancet"},{"key":"ref13","unstructured":"ClinicalTrials.gov. Study NCT03235479. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03235479. Accessed July 26, 2023."},{"key":"ref14","unstructured":"ClinicalTrials.gov. Study NCT03237845. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03237845. Accessed July 26, 2023."},{"key":"ref15","unstructured":"ClinicalTrials.gov. Study NCT03461757. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03461757. Accessed July 26, 2023."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241232944","volume":"44","author":"Croop","year":"2024","journal-title":"Cephalalgia"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1111\/head.13930","volume":"60","author":"Berman","year":"2020","journal-title":"Headache"}],"container-title":["Journal of Pain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=99279","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=99279","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T01:35:20Z","timestamp":1716255320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/safety-of-rimegepant-in-patients-using-preventive-migraine-medications-peer-reviewed-fulltext-article-JPR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":17,"URL":"https:\/\/doi.org\/10.2147\/jpr.s453937","relation":{},"ISSN":["1178-7090"],"issn-type":[{"value":"1178-7090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]}}}